Clinical outcomes and survival of advanced renal cancer patients in Phase I clinical trials.

被引：0
|
作者：
Malik, Laeeq [1 ]
Parsons, Helen [2 ]
Mahalingam, Devalingam [1 ]
Ehler, Benjamin [2 ]
Goros, Martin [2 ]
Brenner, Andrew [1 ]
Sarantopoulos, John [1 ]
机构：
[1] Univ Texas Hlth Sci Ctr San Antonio, Inst Drug Dev, Canc Therapy & Res Ctr, San Antonio, TX 78229 USA
[2] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA
来源：
MOLECULAR CANCER THERAPEUTICS | 2013年 / 12卷 / 11期
关键词：
D O I：
10.1158/1535-7163.TARG-13-A70
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A70
引用
收藏
页数：2
相关论文
共 50 条
  • [11] Clinical outcome of patients with metastasic melanoma undergoing phase I clinical trials.
    Blanco-Codesido, M.
    Brunetto, A.
    Frentzas, S.
    Garcia, V. Moreno
    Papadatos-Pastos, D.
    Pedersen, J. V.
    Trani, L.
    Puglisi, M.
    Sarker, D.
    Molife, L. R.
    Banerji, U.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [12] Biomarker selection for patients participating in phase I clinical trials.
    Eberst, Lauriane
    Basse, Clemence
    Morelle, Magali
    Simmet, Victor
    Terret, Catherine
    Pissaloux, Daniel
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [13] Socioeconomic deprivation and cancer outcomes in patients treated in clinical trials.
    Unger, Joseph M.
    Moseley, Anna
    Ramsey, Scott David
    Osarogiagbon, Raymond U.
    Symington, Banu
    Hershman, Dawn L.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (27)
  • [14] Clinical outcomes of adolescents and young adults (AYA) with advanced solid tumors participating in phase I trials.
    Sundar, Raghav
    McVeigh, Terri Patricia
    Petruckevitch, Ann
    Diamantis, Nikolaos
    Ang, Joo Ern
    Chenard-Poirier, Maxime
    Collins, Dearbhaile Catherine
    Lim, Joline Si Jing
    Ameratunga, Malaka
    Khan, Khurum Hayat
    Kaye, Stanley B.
    Banerji, Udai
    Lopez, Juanita Suzanne
    De Bono, Johann S.
    Van Der Graaf, Winette T. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [15] Advanced Cancer Patients' Understanding and Perceptions of Phase I Clinical Trials
    Pawlowski, Jamie
    Malik, Laeeq
    Mahalingam, Devalingam
    CANCER INVESTIGATION, 2015, 33 (10) : 490 - 495
  • [16] Clinical outcomes of patients with metastatic breast cancer enrolled in phase I clinical trials
    Criscitiello, Carmen
    Marra, Antonio
    Morganti, Stefania
    Zagami, Paola
    Gandini, Sara
    Esposito, Angela
    Curigliano, Giuseppe
    EUROPEAN JOURNAL OF CANCER, 2021, 157 : 40 - 49
  • [17] Survival of patients with gastrointestinal malignancies participating in phase 1 clinical trials.
    Denson, Aaron Cleveland
    Burke, Nancy
    Bertels, Barbara
    Wapinsky, Georgine
    Juan, TzuHua
    Lee, Jae K.
    Sullivan, Daniel
    Mahipal, Amit
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [18] Baseline predictors of hematological toxicity in patients with advanced cancer treated with ATR inhibitors in phase I/II clinical trials.
    Ngoi, Natalie
    Lin, Heather Y.
    Dumbrava, Ecaterina Elena
    Fu, Siqing
    Karp, Daniel D.
    Naing, Aung
    Pant, Shubham
    Piha-Paul, Sarina Anne
    Ahnert, Jordi Rodon
    Subbiah, Vivek
    Tsimberidou, Apostolia Maria
    Campbell, Erick
    Urrutia, Samuel
    Hong, David S.
    Meric-Bernstam, Funda
    Yuan, Ying
    Yap, Timothy A.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [19] Characteristics and survival of patients with advanced cancer and TP53 mutations in phase I clinical trials
    Said, Rabih
    Ye, Yang
    Hong, David S.
    Janku, Filip
    Fu, Siqing
    Naing, Aung
    Wheler, Jennifer J.
    Kurzrock, Razelle
    Thomas, Christoforos
    Palmer, Gary A.
    Hess, Kenneth R.
    Wolff, Robert A.
    Tsimberidou, Apostolia Maria
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [20] Looking beyond the first cycle in phase I cancer clinical trials.
    Lee, Shing Mirn
    Cheung, Ying Kuen
    Hershman, Dawn L.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345